A well-established rat model of diet-induced metabolic syndrome was used to evaluate the effects of the oral administration of spores or cells of HU16, a carotenoid-producing strain of Bacillus indicus. Symptoms of metabolic syndrome were induced in 90-day old, male Sprague-Dawley rats maintained for eight weeks on a high-fat diet, as previously reported. Parallel groups of animals under the same diet regimen also received a daily dose of 1×10 10 cells or spores of B. indicus HU16. Cells of strain HU16 were able to reduce symptoms of metabolic syndrome, plasma markers of inflammation and oxidative markers in plasma and liver to levels similar to those observed in rats under a standard diet. HU16 cells did not affect obesity markers or the accumulation of triglycerides in the liver of treated animals. Denaturing gradient gel electrophoresis analysis showed that the oral administration of HU16 cells did not significantly affect the gut microbiota of high fat-fed rats, suggesting that the observed beneficial effects are not due to a reshaping of the gut microbiota but rather to metabolites produced by HU16 cells.
Introduction
Diet plays an important role in the aetiology and prevention of the risk factors for the metabolic syndrome (O'Keefe et al., 2008; Salas-Salvadó et al., 2016) . Many epidemiological studies have shown a strong inverse association between consumption of fruits and vegetables and the incidence of cardiovascular diseases (Bazzano et al., 2002; Crowe et al., 2011; Mirmiran et al., 2009) . In addition, the intake of antioxidant phytochemicals has been associated with a reduction in the risk of type-2 diabetes (Cooper et al., 2012; Dembinska-Kiec et al., 2008; Hamer and Chida, 2007) .
It is known that micronutrient antioxidants, such as vitamins and carotenoids, are decreased in both the serum and liver tissue of patients with chronic liver disease and cirrhosis (Leo et al., 1993; Ruhl and Everhart, 2003; Yadav et al., 2002) . In addition, obesity is associated with low serum concentrations of carotenoids (α-carotene and β-carotene) and vitamin E (Gunanti et al., 2014; Neuhouser et al., 2001; Ruhl and Everhart, 2003) . Thus, these micronutrient antioxidant deficiencies may also contribute to the development of greater adiposity and comorbidities, such as insulin resistance and hepatic steatosis. Importantly, carotenoids are as potent in inhibiting lipid peroxidation as vitamin E (Rock et al., 1996) .
The potential health-promoting properties of carotenoids have led to a substantial interest in carotenoids as nutritional supplements, especially from natural sources. Carotenoidproducing bacteria have received interest in recent years due to the fact that many species are thought to be probiotics (Hempel et al., 2012; Ma et al., 2010) coupled with their ability to provide a suitable biosource of carotenoids with both C40 and C30 backbones for the food and feed industry. In particular, spore-forming bacteria of the Bacillus genus have been reported to produce carotenoids with improved stability (Duc et al., 2006) and solubility (Sy et al., 2015) . Although these bacteria are not photosynthetic organisms, several isolates produce carotenoids , that are essential for the cellular response to oxidative stress conditions (Manzo et al., 2011 (Manzo et al., , 2013 . Spore-forming bacteria share the ability to differentiate, producing a dormant spore, a highly resistant cell form able to survive harsh and extreme environmental conditions. Carotenoids are needed for the protection of cells but not of spores from reactive oxygen species (Manzo et al., 2013) , however in some species including Bacillus indicus HU36, carotenoids have been found associated with both cells and spores (Duc et al., 2006) .
Beneficial effects of carotenoid-producing cells of Bacillus indicus
We set out to investigate whether carotenoid-producing bacteria were able to counteract symptoms of metabolic syndrome induced in a rat model using a long-term dietary treatment with a high fat diet. To this aim we used B. indicus HU16, a previously characterised bacterium isolated from human faeces with a notable capacity to produce a yelloworange carotenoid .
Methods
Bacterial growth, sporulation and spore purification B. indicus HU16 was grown in LuriaBertani medium at 37 °C in aerobic conditions. Cells were collected at the stationary phase of growth after 18 h of culture, washed two times and stored at -20 °C. Sporulation was induced in Difco Sporulation (DS) medium (Difco, Detroit, MI, USA) by the exhaustion method (Cutting and Vander Horn, 1990) . After a 48 h incubation at 37 °C, spores were collected, washed four times, purified by using overnight incubation in H 2 O at 4 °C to lyse residual sporangial cells (Nicholson and Setlow, 1990) . To obtain the total number of cells and spores needed for the whole experimental period, various preparations were pulled together and counted using a cell counting chamber. 1 ml aliquots each containing 1×10 10 cells or spores suspended in a 10% (v/v) sucrose solution were immediately frozen and kept at -20 °C until needed for the animal treatment.
Animals and treatments
Male Sprague-Dawley rats (90-days old; Charles River, Italy) were caged singly in a temperature-controlled room (23±1 °C) with a 12 h light/dark cycle (06.30-18.30) . Treatment, housing and euthanasia of animals met the guidelines set by the Italian Health Ministry. All experimental procedures involving animals were approved by Comitato Etico-Scientifico per la Sperimentazione Animale of the University Federico II of Naples. Rats were fed either a standard low fat diet (Group 1, n=6) or a high fat diet (n=18), previously reported to induce symptoms of metabolic syndrome and obesity (Crescenzo et al., 2008) . The dietary treatment lasted eight weeks. The composition of the two diets is shown in Table 1 .
Rats fed a high fat diet were subdivided into three groups (each composed of 6 rats), receiving each day by oral gavage 1 ml of a 10% sucrose solution alone (Group 2) or containing 1×10 10 cells (Group 3) or 1×10 10 spores (Group 4) of B. indicus HU16 (Table 2) .
During the treatments, body weight, food and water intake were monitored daily. Faeces were also collected daily and their energy content assessed with a bomb calorimeter, as previously reported (Crescenzo et al., 2010) . At the end of the experimental period, the rats were euthanised by decapitation. Portal blood, systemic blood, caecum and 
Insulin tolerance test, glucose tolerance test, plasma metabolites
Insulin tolerance tests (ITT) were carried out after 4 and 8 weeks of treatment. Rats were fasted for 6 h from 09:00 AM. Basal, post-absorptive blood samples were obtained from a small tail clip and placed in EDTA-coated tubes and then insulin (2.5 IU/kg body weight) was injected by the intraperitoneal route. Blood samples were collected after 20, 40, 60, 90 and 120 min and placed in EDTA-coated tubes. The blood samples were centrifuged at 1,400×g for 8 min at 4 °C. Plasma glucose concentration was measured by colorimetric enzymatic method (Pokler Italia, Genova, Italy).
Glucose tolerance test (GTT) was carried out after 8 weeks of treatment. To this end, rats were fasted for 6 h from 09:00 AM. Basal, postabsorptive blood sample was obtained from a small tail clip and placed in EDTA-coated tubes and then glucose (2 g/kg body weight) was injected intraperitoneally. Blood samples were collected after 20, 40, 60, 90 and 120 min and placed in EDTA-coated tubes. The blood samples were centrifuged at 1,400×g for 8 min at 4 °C. Plasma glucose concentration was measured by colorimetric enzymatic method (Pokler Italia, Genova, Italy), while plasma insulin concentration was measured using an ELISA kit (Mercodia AB, Uppsala, Sweden) in a single assay to remove inter-assay variations.
Plasma concentrations of alanine aminotransferase, triglycerides, cholesterol and non-esterified fatty acids (NEFA) were measured using a colorimetric enzymatic method using commercial kits (SGM Italia, Rome, Italy). Lipid peroxidation was determined according to Fernandes et al. (2006) , by measurement of thiobarbituric acid reactive substances (TBARS), using the thiobarbituric acid assay.
Plasma lipopolysaccharide (LPS) determinations were performed by a Limulus amaebocyte lysate (LAL) kit (Lonza, Basel, Switzerland) using a LAL extract according to the manufacturer's instruction. Briefly, samples were mixed with the LAL reagent and chromogenic substrate reagent for 16 min and absorbance readings were performed on a plate reader at 405 nm. Tumour necrosis factor (TNF)-α concentrations in plasma samples were determined using a rat-specific enzyme linked immunosorbent assay (R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instruction.
Body composition and energy balance
After livers removal, guts were cleaned of undigested food and the carcasses were then autoclaved. After dilution in distilled water and subsequent homogenisation of the carcasses with a Polytron homogeniser (Kinematica, Luzern, Switzerland), duplicate samples of the homogenised carcasses were analysed for energy content using a bomb calorimeter. To take into account the energy content of liver, tissue samples were dried and the energy content was then measured with the bomb calorimeter. Total body water content was determined by drying carcass samples in an oven at 70 °C for 48 h. Total body lipids were measured by the Folch extraction method (Folch et al., 1957) . Energy balance measurements were conducted by the comparative carcass technique over the experimental period, as detailed previously (Crescenzo et al., 2010) .
Liver composition, and hepatic tissue and mitochondrial oxidative stress
Liver triglycerides and TBARS were measured as described above for plasma samples. Isolation of liver mitochondria was carried out as previously reported (Crescenzo et al., 2014) . Lipid peroxidation was determined in isolated mitochondria by using the same procedure used for plasma samples.
PCR-DGGE analysis
Bacterial 16S rDNA fragments were amplified using nested PCR. For the primary amplification, PCR was conducted with the primers 27F and 1492R (Chong et al., 2009 (Hammer et al., 2001 ).
Statistical analysis
Data are reported as means with their standard errors (SEM). Statistical analyses were performed by one way ANOVA followed by the Tuckey post-test. The MannWhitney U-test was applied to the PCA scores in order to evaluate the effect of the oral administration of a daily dose of 1×10 10 cells of B. indicus HU16 on gut microbiota of rats under a high fat diet. Probability values less than 0.05 were considered to indicate a significant difference. All analyses were performed using GraphPad Prism 6 (GraphPad Software, San Diego, CA, USA).
Materials
All chemicals used were of analytical grade and were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Results

Cells but not spores of Bacillus indicus HU16 rescued early signs of diet-induced metabolic syndrome
After 4 weeks of dietary treatment, insulin tolerance tests were carried out to screen the efficacy of the treatment with spores or cells. The cumulative change in plasma glucose after insulin injection assessed through the measurement of area under the curve indicated that after 4 weeks of dietary treatment, high fat fed rats had already developed insulin resistance (Figure 1 ). The same effect was evident also in high fat fed rats treated with HU16 spores, while those that had received HU16 cells exhibited a glucose response to insulin very similar to that of low fat fed rats and were, therefore, protected by the diet-induced insulin resistance (Figure 1 ).
Since only cell-treated rats showed an improvement in glucose homeostasis compared to high fat fed rats, the dietary treatment was continued up to 8 weeks only for low fat-fed (Group 1), high fat-fed (Group 2) and high fat-fed rats receiving B. indicus cells (Group 3).
Cells of Bacillus indicus HU16 did not affect obesity markers
High fat dietary consumption sustained the development of diet-induced obesity, as shown by: (1) the significant increase in body weight and body lipids, with a concomitant decrease in body water (Table 3) ; (2) the altered plasma lipid profile, with a significant increase in triglycerides, cholesterol and NEFA (Table 4) ; and (3) the increased deposition of triglycerides in the liver (Table 4 ). All these obesity markers were not affected by the daily treatment with 1×10 10 cells of B. indicus HU16 (Table 3 and 4). 
Cells of Bacillus indicus HU16 rescued signs of dietinduced metabolic syndrome and oxidative damage
As previously reported (Crescenzo et al., 2008) , at the end of the 8-week period, high fat fed rats exhibited whole body insulin resistance (Figure 2 ). In fact, the decrease in plasma glucose concentration induced by a given dose of insulin was lower, and the increase in plasma insulin induced by a given dose of glucose was higher, in high fat fed rats compared to low fat fed rats (Figure 2) . In both tests, the treatment with 1×10 10 cells of B. indicus HU16 was protective against the development of insulin resistance (Figure 2 ).
Eight weeks of high fat diet also elicited a significant increase in systemic inflammation markers LPS and TNF-α, as well as an increase in oxidative damage of plasma lipids and hepatic necrosis (Table 4) . These metabolic derangements were prevented by the administration of a daily dose of 1×10 10 cells of B. indicus HU16 (Table 4) . Oxidative stress was enhanced by eight weeks of high fat feeding in whole liver tissue and at the mitochondrial level (Table 4) , but in this case the treatment of high fat fed rats with 1×10 10 cells of B. indicus HU16 was protective (Table 4) .
Eight weeks of treatment with HU16 cells did not affect the gut microbiota of high fat-fed rats
The majority of the samples from high fat fed animals treated (Group 3, purple symbols) or not treated (Group 2, green symbols) with HU16 cells clustered together, while samples from two rats of each group were arranged separately ( Figure 3 ). The Mann-Whitney U test performed on the PCA scores did not identify any statistically significant difference between the two groups. Therefore, the DGGE analysis suggests that the oral administration of a daily dose of 1×10 10 cells of B. indicus HU16 did not affect the microbial composition of the animal gut.
Discussion
A high fat diet was used in the present study to mimic human diets that have been associated with the development of the metabolic syndrome. In fact, this diet induced changes in metabolic and hepatic functions, such as excessive abdominal fat deposition, impaired glucose tolerance and increased plasma lipid concentrations (Crescenzo et al., 2008) , together with increased plasma oxidative stress markers and liver transaminase compared with low-fat diet fed rats. On this animal model, we tested the hypothesis that the administration of the carotenoidproducing bacterial strain B. indicus HU16 could reverse obesity and/or associated metabolic syndrome induced by long-term dietary treatment with a high fat diet. At variance with results obtained with marine carotenoid fucoxanthin (Gammone and D'Orazio, 2015) , simultaneous administration of carotenoid-producing bacterial cells did not affect the development of high fat diet-induced obesity nor abolished the modifications of plasma lipid profile. Interestingly, however, the most relevant high fatassociated metabolic impairment, i.e. insulin resistance, was completely reversed by bacterial administration. In addition, although plasma lipids were increased in high fat fed rats receiving bacterial cells, this treatment abolished the increase in peroxidised lipids, suggesting that the condition of increased oxidative stress elicited by high fat diet is prevented by bacterial administration. This result is interesting, since oxidative stress is today considered a leading cause for the onset of obesity-associated insulin resistance (Bettaieb et al., 2014; Rains and Jain, 2011) .
Obesity is also associated with metabolic endotoxemia and a proinflammatory state, that contribute to the metabolic derangement observed both in human and animals (Cani et al., 2007; Di Luccia et al., 2015; Gomes et al., 2017) . We therefore looked at this aspect in our experiments to verify whether bacterial administration could exert an influence on the above parameters and we found a protective effect of these bacteria with regard to metabolic endotoxemia and inflammation. In addition, bacteria also exerted a protective effect on liver necrosis and therefore we looked at liver function more in depth. One important and deleterious consequence of high fat feeding and obesity is the development of hepatic triglyceride deposition, that represents the first step on the way to the development of non-alcoholic steatohepatitis, the second step being represented by oxidative stress (Asrih and Jornayvaz, 2015) . High fat diet resulted in the increased triglyceride deposition, accompanied by increased lipid peroxidation in the liver and plasma of rats. The administration of Bacillus bacteria prevented these adverse effects of high fat diet and appears to be protective against oxidative stress. Mitochondria are primary cellular sites of production of reactive oxygen species and we looked at the oxidative damage in these organelles. Hepatic mitochondria isolated from rats fed a high fat diet showed a high degree of oxidative stress, while in rats fed a high fat diet and supplemented with bacteria, the degree of oxidative stress was found to be identical to that of rats fed low fat diet, thus suggesting that bacterial supplementation exerts a protective role also on mitochondria.
It is well established that the diet is a main factor involved in shaping the microbial composition of the gut (De Filippo et al., 2010) and that a high fat diet alters the gut microbiota both in animal models (Di Luccia et al., 2015; Rabot et al., 2016) and in humans (Sonnenburg and Backed, 2016) . Such alterations have been linked to the development of the metabolic syndrome and obesity (Murphy et al., 2015) . We observed by DGGE analysis that the oral administration of a daily dose of 1×10 10 cells of B. indicus HU16 to high fat fed rats did not significantly alter the microbial composition of the gut. Although a metagenomic approach would be needed to completely rule out the possibility that HU16 cells had an effect on the gut microbiota, our DGGE analysis suggests that major alterations in the gut composition had not occurred. Based on this, we hypothesise that HU16 cells produce metabolites able to directly reduce the oxidative damages caused by the high fat diet. Because of the wellknown anti-oxidant activity of carotenoids, the carotenoids produced by HU16 cells are an obvious candidate. Verifying this hypothesis will require new in vivo experiments with the purified carotenoid and a HU16 mutant unable to produce the carotenoid and will be a challenging task for future work. An additional question raised by this work is why HU16 spores do not show any beneficial effect in our rat model of diet-induced metabolic syndrome. It has been elegantly demonstrated that B. subtilis spores once ingested can perform an entire life cycle in the mouse gastrointestinal tract, germinating in the upper part of the intestine, undergoing few rounds of growth and then sporulating the lower intestine (Casula and Cutting, 2002) . A similar evidence is not currently available for either the rat gastrointestinal tract or the B. indicus spore. Therefore, we hypothesise that in the rat intestine HU16 spores either: (1) do not germinate; (2) germinate with a very low efficiency; or (3) that germinated spores are unable to grow. According to this hypothesis cells but not spores have a beneficial, probiotic role. Further work will be needed to address this hypothesis. 
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